What is Auranofin Market Scope?
Auranofin is a gold-containing salt. It is used for treating arthritis and is classified as an antirheumatic agent by World Health Organization and is also called a disease-modifying antirheumatic drug (DMARD). Antirheumatic drugs are the ones that are used in the treatment of rheumatism. Auranofin is known by different names in different countries. Auranofin improves arthritis symptoms like pain, tender, and swollen joints, and morning stiffness.
The Auranofin market study is being classified, by Application (Pharmaceuticals and Dietary Supplements) and major geographies with country level break-up.
The global Auranofin market is consolidated as fewer manufacturers are supplying the product for the end-user industry. More industrialists and manufacturers are showing a keen interest in the Auranofin as the demand for the auranofin, due to the rising population with arthritis is growing. This will create opportunity and players should develop such derivatives that don’t have severe after-effects and relieve pain more efficiently and aid in curing the disease permanently.
Ferro Pfanstiehl Laboratories, Inc. (United States), Prometheus laboratories inc. (United States), Johnson Matthey Inc. (United Kingdom), Lek Pharmaceuticals d.d (Slovenia), Medichem SA (Spain) and Lonza Group Ltd. (Switzerland) are some of the key players profiled in the study.
Segmentation Analysis
Analyst at AMA have segmented the market study of Global Auranofin market by Type, Application and Region.
On the basis of geography, the market of Auranofin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Auranofin is a gold salt classified by the World Health Organization as an antirheumatic agent.
Market Drivers
- Increasing Demand for Auranofin Owing to Rising Arthritis Demographics
Opportunities
- Increasing Health Issues across the World and Rising Cases of Rheumatoid Arthritis
- Increasing R&D in Auranofin
Restraints
- Availability of Raw Material
Challenges
- Lack of Awareness Regarding the Use of Auranofin
Key Target Audience
Auranofin Manufacturers, Raw Material Suppliers, Potential Investors, End-Use Industry and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.